- Home
- IGC vs PSHG Comparison
IGC vs PSHG Comparison
Compare IGC & PSHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGC
- PSHG
- Stock Information
- Founded
- IGC 2005
- PSHG 2010
- Country
- IGC United States
- PSHG Greece
- Employees
- IGC N/A
- PSHG N/A
- Industry
- IGC Biotechnology: Pharmaceutical Preparations
- PSHG Marine Transportation
- Sector
- IGC Health Care
- PSHG Consumer Discretionary
- Exchange
- IGC Nasdaq
- PSHG Nasdaq
- Market Cap
- IGC 20.2M
- PSHG 20.8M
- IPO Year
- IGC N/A
- PSHG N/A
- Fundamental
- Price
- IGC $0.31
- PSHG $1.94
- Analyst Decision
- IGC Strong Buy
- PSHG Strong Buy
- Analyst Count
- IGC 2
- PSHG 1
- Target Price
- IGC $3.88
- PSHG $6.50
- AVG Volume (30 Days)
- IGC 230.9K
- PSHG 166.6K
- Earning Date
- IGC 08-07-2025
- PSHG 07-24-2025
- Dividend Yield
- IGC N/A
- PSHG N/A
- EPS Growth
- IGC N/A
- PSHG N/A
- EPS
- IGC N/A
- PSHG 1.58
- Revenue
- IGC $1,236,000.00
- PSHG $86,407,000.00
- Revenue This Year
- IGC N/A
- PSHG N/A
- Revenue Next Year
- IGC $16.45
- PSHG $23.25
- P/E Ratio
- IGC N/A
- PSHG $1.23
- Revenue Growth
- IGC 1.65
- PSHG N/A
- 52 Week Low
- IGC $0.25
- PSHG $1.31
- 52 Week High
- IGC $0.55
- PSHG $2.34
- Technical
- Relative Strength Index (RSI)
- IGC 49.31
- PSHG 63.65
- Support Level
- IGC $0.30
- PSHG $1.78
- Resistance Level
- IGC $0.32
- PSHG $2.34
- Average True Range (ATR)
- IGC 0.02
- PSHG 0.14
- MACD
- IGC -0.00
- PSHG 0.03
- Stochastic Oscillator
- IGC 20.00
- PSHG 47.37
About IGC IGC Pharma Inc.
IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.
About PSHG Performance Shipping Inc.
Performance Shipping Inc is a provider of shipping transportation services through its ownership of tanker vessels. The company's vessels are employed on time charters with liner companies carrying containerized cargo along various shipping routes. It owns and operates six Aframax tanker vessels.